You are here

Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche tests 'brain shuttle' in humans in Alzheimer's project

Reuters

Mon, 11/11/19 - 08:00 pm

Tags:

Roche, Alzheimer's disease, monoclonal antibodies, gantenerumab

Roche steers Gazyva into a new PhIII program after combo shows promise in lupus nephritis study

Endpoints

Mon, 11/11/19 - 11:04 am

Tags:

Roche, monoclonal antibodies, Gazyva, lupus, kidney disease, clinical trials

Roche sets sights on Novartis, Biogen as SMA trial hits target

Yahoo/Reuters

Mon, 11/11/19 - 10:49 am

Tags:

Roche, SMA, risdiplam, Biogen, Novartis, clinical trials

Roche joins others in dropping myostatin inhibitor for DMD

Pharmaforum

Fri, 11/8/19 - 10:50 am

Tags:

Roche, Duchenne Muscular Dystrophy, RG6206, myostatin inhibitors

Roche escapes lawsuit claiming it illegally quashed Biocad's biosimilar hopes

Fierce Pharma

Thu, 11/7/19 - 11:13 pm

Tags:

Roche, Biocad, Russia, biosimilars

Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.

Fierce Pharma

Thu, 11/7/19 - 11:05 am

Tags:

Roche, Teva Pharmaceutical, Celltrion, Rituxan, biosimilars, MabThera, Truxima

Top execs from AstraZeneca, Roche, Sanofi and GSK tout China investments at import expo

Fierce Pharma

Thu, 11/7/19 - 10:21 am

Tags:

China, AstraZeneca, Roche, Sanofi, GSK

Roche pays $200M for rights to Dicerna's hepatitis B RNAi drug

Fierce Biotech

Thu, 10/31/19 - 10:29 am

Tags:

Roche, Dicerna Pharmaceuticals, RNAi, hepatitis B, DCR-HBVS

Bay Area Life Sciences Professionals Weigh In on Their Ideal Employers

BioSpace

Tue, 10/29/19 - 10:23 am

Tags:

San Francisco, Bay Area, Genentech, Gilead Sciences, Roche, Amgen

Why Roche's Acquisition Of Spark May Be Complete By Year's End

Investors Business Daily

Sat, 10/26/19 - 02:14 pm

Tags:

Roche, Spark Therapeutics, M&A

Diagnostics specialists win the US device approval race

EP Vantage

Fri, 10/25/19 - 10:35 am

Tags:

devices, diagnostics, Roche, FDA

Roche's Tecentriq scores a first-in-class double win in new liver cancer patients

Fierce Pharma

Mon, 10/21/19 - 04:36 pm

Tags:

Roche, liver cancer, Tecentriq, immuno-oncology, Avastin, Nexavar

FDA approves Roche’s Xofluza for patients at high risk of developing flu-related complications

Pharmaceutical Business Review

Fri, 10/18/19 - 07:48 pm

Tags:

Roche, FDA, Xofluza, vaccines, influenza

A change of the guard for the world’s biggest cancer companies

EP Vantage

Fri, 10/18/19 - 10:16 am

Tags:

cancer, Bristol-Myers Squibb, Celgene, M&A, Roche, AstraZeneca

With biosimilar threat under control (for now), Roche savors demand for its new drugs

Endpoints

Wed, 10/16/19 - 12:24 pm

Tags:

Roche, M&A, Spark Therapeutics, China

Staying Ahead of Biosimilar Competition, Roche's Rituxan Shows Superiority in Rare Autoimmune Skin Disease

BioSpace

Mon, 10/14/19 - 11:06 am

Tags:

Roche, clinical trials, Rituxan/MabThera, MMF, pemphigus vulgaris

Roche vice chairman says short-term profit hunger 'destroyed the planet'

Yahoo/Reuters

Fri, 10/11/19 - 10:26 am

Tags:

Roche, environmental concerns

Novartis' ligelizumab outperforms Roche's Xolair in chronic urticaria clearance

Pharmafile

Wed, 10/9/19 - 11:10 pm

Tags:

Novartis, clinical trials, ligelizumab, Roche, Xolair, chronic urticaria

Humira, Rituxan top list of U.S. drugs with biggest price increases -report

Yahoo/Reuters

Tue, 10/8/19 - 09:23 am

Tags:

ICER, drug pricing, AbbVie, Humira, Roche, Rituxan

After more than a year, Gilead finds new chief medical officer

Biopharma Dive

Mon, 10/7/19 - 12:04 pm

Tags:

Gilead Sciences, Roche, Genentech

Pages

last 30 twitter posts